عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Minister Hasan: Lebanon Records Three Cases of the COVID-19 Delta Variant

 
أعلن وزير الصحة العامة في حكومة تصريف الاعمال الدكتور حمد حسن، وجود ثلاث حالات "دلتا" ايجابية. ودعا المواطنين في خلال حملة تلقيح في منطقة ضهور الشوير، في حضور النائب الياس بو صعب الى الاقبال على التلقيح، لانه الطريق الوحيد للحماية اضافة للاجراءات الوقائية".

وأكد "أن برنامج الترصد الوبائي في وزارة الصحة العامة يعمل على تحديد مصدر هذه الحالات".
    1
    2
    3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
J06BA02 KIOVIG BioHuman Human normal immunoglobulin G - 5g/50ml 5g/50ml Injectable solution 28,561,957 L.L
J06BA02 KIOVIG BioHuman Human normal immunoglobulin G - 10g/100ml 10g/100ml Injectable solution 52,750,347 L.L
L01EF02 KISQALI B Ribociclib - 200mg 200mg Tablet, film coated 211,296,306 L.L
L01EF02 KISQALI B Ribociclib - 200mg 200mg Tablet, film coated 3,465,774 L.L
L01FD01 KANJINTI BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 34,591,494 L.L
L01FD01 KANJINTI BioTech Trastuzumab - 420mg 420mg Injectable powder for concentrate for solution 79,305,881 L.L
L01FD01 KANJINTI BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 5,659,423 L.L
L01FD01 KANJINTI BioTech Trastuzumab - 420mg 420mg Injectable powder for concentrate for solution 1,300,809 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 100mg 100mg Injectable powder for concentrate for solution 135,545,977 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 160mg 160mg Injectable powder for concentrate for solution 216,872,714 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 100mg 100mg Injectable powder for concentrate for solution 2,223,284 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 160mg 160mg Injectable powder for concentrate for solution 3,557,240 L.L
L01FF02 KEYTRUDA BioTech Pembrolizumab - 100mg/4ml 100mg/4ml Injectable solution 241,744,958 L.L
L01FF02 KEYTRUDA BioTech Pembrolizumab - 100mg/4ml 100mg/4ml Injectable solution 3,965,206 L.L
L01XA02 KARBOTEEN G Carboplatin - 150mg/15ml 150mg/15ml Injectable solution 2,666,184 L.L
L01XA02 KEMOCARB G Carboplatin - 150mg/15ml 150mg/15ml Injectable solution 1,194,904 L.L
L01XA02 KEMOCARB G Carboplatin - 450mg/45ml 450mg/45ml Injectable solution 3,519,120 L.L
L01XG02 KYPROLIS B Carfilzomib - 60mg 60mg Injectable powder for solution 1,813,283 L.L
L01XG02 KYPROLIS B Carfilzomib - 60mg 60mg Injectable powder for solution 110,549,631 L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution 1,583,534 L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution 96,542,598 L.L
M01AB15 KETOLAC G Ketorolac trometamine - 10mg 10mg Tablet 106,164 L.L
M01AB15 KETO-AVI G Ketorolac tromethamine - 30mg/ml 30mg/ml Injectable solution 106,164 L.L
M01AB15 KETOLAC G Ketorolac trometamine - 30mg/2ml 30mg/2ml Injectable solution 106,164 L.L
M01AE03 KETOPROFENE MACOPHARMA G Ketoprofen - 100mg/100ml 100mg/100ml Injectable solution 329,241 L.L
M01AE17 KETESSE B Dexketoprofen (trometamol) - 25mg 25mg Tablet, film coated 399,121 L.L
M01AE17 KETESSE B Dexketoprofen (trometamol) - 50mg/2ml 50mg/2ml Injectable concentrated solution 649,076 L.L
M01AE17 KETESSE B Dexketoprofen (trometamol) - 50mg/2ml 25mg Tablet, film coated 435,405 L.L
M02AA10 KETOSPRAY G Ketoprofen - 10% 10% Spray, solution 1,255,149 L.L
N01AX03 KETAMINE PANPHARMA G Ketamine HCl - 250mg/5ml 250mg/5ml Injectable solution 1,534,668 L.L
    1
    2
    3
Sitemap
© Copyrights reserved to Ministry of Public Health 2024